Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne
Public ClinicalTrials.gov record NCT00031096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week, Randomized, Double-blind, Multicenter Study Comparing the Clinical Efficacy and Safety of Azelaic Acid 15% Gel (SH H 655 BA) With Its Vehicle (SH H 655 PBA) in Patients With Mild to Moderate Acne.
Study identification
- NCT ID
- NCT00031096
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- LEO Pharma
- Industry
- Enrollment
- 879 participants
Conditions and interventions
Conditions
Interventions
- Azelaic Acid Gel 15% (Finacea, BAY39-6251) Drug
- Vehicle gel (SH H 655 PBA) Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2001
- Primary completion
- Jun 30, 2002
- Completion
- Jun 30, 2002
- Last update posted
- Jun 8, 2023
2002
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Newnan | Georgia | 30263 | — |
| Not listed | Shawnee Mission | Kansas | 66203 | — |
| Not listed | Wichita | Kansas | 67206 | — |
| Not listed | Lexington | Kentucky | 40509 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Bay Shore | New York | 11706 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cincinnati | Ohio | 45230 | — |
| Not listed | Portland | Oregon | 97223-6683 | — |
| Not listed | Hershey | Pennsylvania | 17033 | — |
| Not listed | Knoxville | Tennessee | 37922 | — |
| Not listed | Bryan | Texas | 77802 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00031096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00031096 live on ClinicalTrials.gov.